A more recent paper showed that GLI1 and GLI2 were activated by Insulin like growth factor (IGF-1)-mediated activation of the PI3K/AKT pathway in renal cell carcinoma. This evidence concerns the gene AKT1 and hereditary clear cell renal cell carcinoma.